Evidence map›Paper›PMID 42506057›Full record

ArticleNeurology international2026

Subependymal Giant Cell Astrocytoma Without Clinical Evidence of Tuberous Sclerosis Complex: Diagnostic and Molecular Insights-Case Report.

José Guilherme Jasper Pickler, Hercílio Fronza Junior, Francis Rossetti Pedack, Luisa Andrade Gabardo, Gabriel Coelho Barros, Suzana Bastos Batista, Bruna Louise Silva, Paulo Henrique Condeixa de França, Rafael Roesler, Karina Munhoz de Paula Alves Coelho

Abstract readCase Reports
In one paragraph

Article in Neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

José Guilherme Jasper PicklerDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.
Hercílio Fronza JuniorDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.
Francis Rossetti PedackDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.
Luisa Andrade GabardoDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.
Gabriel Coelho BarrosDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.
Suzana Bastos BatistaDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.
Bruna Louise SilvaDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.ORCID 0000-0001-9756-4846
Paulo Henrique Condeixa de FrançaGraduate Program in Health and Environment, University of the Joinville Region (UNIVILLE), Joinville 89219-710, Brazil.ORCID 0000-0002-1750-9132
Rafael RoeslerNational Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.ORCID 0000-0001-6016-2261
Karina Munhoz de Paula Alves CoelhoDepartment of Scientific Development and Innovation (DECIPE), Center for Anatomo-Pathological Diagnosis (CEDAP), Joinville 89201-330, Brazil.

Funding

Center for Anatomo-Pathological Diagnosis (CEDAP) N/AChildren's Cancer Institute (ICI) N/AConselho Nacional de Desenvolvimento Científico e Tecnológico 304623/2025-3Conselho Nacional de Desenvolvimento Científico e Tecnológico 307616/2023-1Conselho Nacional de Desenvolvimento Científico e Tecnológico 406484/2022-8Conselho Nacional de Desenvolvimento Científico e Tecnológico 441938/2024-8
6 · The paper itself

Abstract

introductionA subependymal giant cell astrocytoma (SEGA) is a benign tumor typically associated with tuberous sclerosis complex (TSC), an autosomal dominant syndrome. CASE REPORT: The patient, a 15-year-old male, presented with headaches, nausea, and visual obscurations, consistent with increased intracranial pressure. Neuroimaging identified a mass in the anterior left lateral ventricle causing unilateral obstruction at the foramen of Monro. During microsurgery, smears showed a low-grade glial tumor with a biphasic mix of elongated astrocytes and large epithelioid-to-gemistocyte-like cells. Gross total resection was achieved. On permanent sections, a tumor with large polygonal, ganglioid, and gemistocytic-like cells was seen. Nuclear pleomorphism, a feature of SEGA, was present. On immunohistochemistry, the tumor was positive for glial fibrillary acidic protein (GFAP), S100, and CD34, and the cells also displayed nuclear staining for TTF-1. A diagnosis of SEGA in the absence of clinical features of TSC was established; however, definitive classification as sporadic remains limited by the lack of molecular data.

conclusionsThis case highlights the importance of evaluating intraventricular masses through the integration of lineage-specific immunohistochemical panels to prevent misclassification of pleomorphic giant cells as high-grade gliomas.

Indexed as

case reportdifferential diagnosisimmunohistochemistryintraventricular tumorpediatric neuro-oncologySEGA without TSCsubependymal giant cell astrocytomathyroid transcription factor-1tuberous sclerosis complex

Identifiers

PMID42506057
PMCPMC13415998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.